Aysa Medica Ltd - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 09334702 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

FOR

AYSA MEDICA LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

Dr S Sharafi

REGISTERED OFFICE:

South Stour Offices

Mersham

Ashford

Kent

TN25 7HS

BUSINESS ADDRESS:

St Elmo

Burgh Heath

Epsom

Surrey

KT17 4LS

REGISTERED NUMBER:

09334702 (England and Wales)

ACCOUNTANTS:

Cassidys Chartered Accountants

South Stour Offices

Roman Road

Mersham

Ashford

Kent

TN25 7HS

CURRENT ASSETS

Debtors

4

3,500

-

Cash at bank

36,710

30,903

40,210

30,903

CREDITORS

Amounts falling due within one year

5

4,729

6,486

NET CURRENT ASSETS

35,481

24,417

TOTAL ASSETS LESS CURRENT LIABILITIES

35,481

24,417

CAPITAL AND RESERVES

Called up share capital

10

10

Retained earnings

35,471

24,407

SHAREHOLDERS' FUNDS

35,481

24,417

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2020 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 May 2021 and were signed by:

Dr S Sharafi - Director

1.	STATUTORY INFORMATION

Aysa Medica Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2019 - 1 ) .

4.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.20

31.12.19

£

£

Trade debtors

3,500

-

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.20

31.12.19

£

£

Taxation and social security

3,815

5,214

Other creditors

914

1,272

4,729

6,486

6.	RELATED PARTY DISCLOSURES

During the year, total dividends of £5,200 (2019 - £31,000) were paid to the director .

Dr Sharafi - Director and Shareholder

At the balance sheet date Aysa Medica Ltd owed Dr Sharafi £194 (2019 - £552).

7.	ULTIMATE CONTROLLING PARTY

The controlling party is Dr S Sharafi.